A carregar...

The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Leslie, Kimberly K., Thiel, Kristina W., Reyes, Henry D., Yang, Shujie, Zhang, Yuping, Carlson, Matthew J., Kumar, Nirmala S., Dai, Donghai D.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816067/
https://ncbi.nlm.nih.gov/pubmed/24223042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/479541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!